| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10070558 | European Journal of Surgical Oncology (EJSO) | 2005 | 6 Pages |
Abstract
This outcome data of nearly 25 years of community practice show that breast cancer patients with axillary lymph node micrometastasis have a significantly worse survival rate than those without independent of age or tumour size. Adjuvant systemic therapy should be contemplated when treating these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
G.P. Kuijt, A.C. Voogd, L.V. van de Poll-Franse, L.J.E.E. Scheijmans, M.W.P.M. van Beek, R.M.H. Roumen,